Poolbeg identifies new potential drug candidates for RSV infections
Poolbeg Pharma says it has successfully identified potential new drug candidates from its respiratory syncytial…
December 21, 2022 - 3 minutes
RSV
Nuance Pharma’s RSV vaccine cleared for trial in China
Nuance Pharma says China’s Center for Drug Evaluation (CDE) has approved its investigational new drug (IND)…
November 14, 2022 - 3 minutes
RSV cases are rising fast in children. Early detection can help.
By Shawn Gaskell, MilliporeSigma RSV-related hospitalizations for 2022 have already surged to unusually high numbers,…
November 14, 2022 - 5 minutes
In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus
AstraZeneca and Sanofi’s Beyfortus (nirsevimab) has been approved in the European Union (EU) for the…
November 14, 2022 - 9 minutes
AI program yields multiple novel RSV drug targets
Poolbeg Pharma says it has made a breakthrough in its Artificial Intelligence (AI) program with…
November 8, 2022 - 3 minutes
Sanofi and AstraZeneca drug, Beyfortus, for RSV in babies and children approved
A drug being developed jointly by Sanofi and AstraZeneca for the prevention of respiratory syncytial…
November 4, 2022 - 2 minutes
Virax Biolabs introduces flu, Covid-19 and RSV rapid test kits
Rapid test kits that can accurately identify infections related to respiratory syncytial virus (RSV), influenza…
November 3, 2022 - 2 minutes
Beyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg Pharma
On this week’s podcast, our guests are Jeremy Skillington, CEO of Poolbeg Pharma; Dani Bach,…
July 22, 2022 - 7 minutes
Vicebio exits stealth to work on next generation RSV vaccine
Vicebio Ltd, a biopharmaceutical company founded by Medicxi in 2019, has launched to accelerate the…
July 21, 2022 - 4 minutes
OneThree Biotech completes build and optimization of AI model for RSV data
Poolbeg Pharma, a clinical stage infectious disease pharmaceutical company, says its artificial intelligence (AI) partner,…
June 27, 2022 - 4 minutes
GSK positive on RSV vaccine for older adults
GSK plc has announced positive headline results from its AReSVi 006 phase III trial. AReSVi…
June 13, 2022 - 3 minutes
